IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. The podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
- What is asymmetric learning, and how does it fuel pharma innovation?
- Why do some organizations outpace others—and what can we learn from them?
- How can we overcome barriers to meaningful progress in healthcare?
- What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.